Comparison of CL Wear Between Two Allergy Drops
Information source: Hom, Milton M., OD, FAAO
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Allergic Conjunctivitis
Intervention: epinastine HCL and olopatadine HCL (Drug)
Phase: Phase 4
Status: Withdrawn
Sponsored by: Hom, Milton M., OD, FAAO Official(s) and/or principal investigator(s):
Milton M Hom, OD FAAO, Study Director, Affiliation: Private Practice
Summary
Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
Clinical Details
Official title: Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind, Primary Purpose: Treatment
Primary outcome: Contact lens objective and subjective clinical performance testing
Detailed description:
Contact lens patients will instill allergy drops and subjective and objective tests will be
performed
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Males or females > 18 years old
- Mild to moderate dry eye symptoms
- Likely to complete all study visits and able to provide informed consent
Exclusion Criteria:
- Current use of topical cyclosporine
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease (blepharitis patients that
are actively being treated or disease that is uncontrollable)
- Ocular surgery within the past 3 months
Locations and Contacts
Additional Information
Starting date: July 2007
Last updated: October 5, 2010
|
